AIDS vaccine models: challenging challenge viruses

Nat Med. 2002 Mar;8(3):207-10. doi: 10.1038/nm0302-207.
No abstract available

MeSH terms

  • AIDS Vaccines* / genetics
  • AIDS Vaccines* / immunology
  • AIDS Vaccines* / therapeutic use
  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • Clinical Trials as Topic
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical
  • HIV Infections* / immunology
  • HIV Infections* / therapy
  • HIV Infections* / virology
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Macaca mulatta
  • Simian Acquired Immunodeficiency Syndrome* / immunology
  • Simian Acquired Immunodeficiency Syndrome* / therapy
  • Simian Acquired Immunodeficiency Syndrome* / virology
  • Simian Immunodeficiency Virus / genetics
  • Simian Immunodeficiency Virus / immunology
  • Time Factors

Substances

  • AIDS Vaccines